Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $180,890 | 92 | 84.9% |
| Food and Beverage | $15,094 | 826 | 7.1% |
| Travel and Lodging | $9,905 | 31 | 4.6% |
| Consulting Fee | $6,450 | 4 | 3.0% |
| Honoraria | $500.00 | 1 | 0.2% |
| Education | $288.82 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $95,372 | 151 | $0 (2024) |
| ABBVIE INC. | $37,461 | 174 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $17,609 | 30 | $0 (2021) |
| Allergan, Inc. | $17,468 | 61 | $0 (2021) |
| Lilly USA, LLC | $16,118 | 34 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $10,529 | 40 | $0 (2022) |
| Egalet US Inc | $5,201 | 61 | $0 (2018) |
| Promius Pharma LLC | $4,328 | 18 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $2,258 | 20 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $1,092 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,486 | 96 | ABBVIE INC. ($7,942) |
| 2023 | $9,710 | 95 | ABBVIE INC. ($8,968) |
| 2022 | $19,984 | 102 | Biohaven Pharmaceutical Holding Company Ltd. ($10,529) |
| 2021 | $58,468 | 125 | AbbVie Inc. ($17,745) |
| 2020 | $28,481 | 78 | Allergan, Inc. ($13,716) |
| 2019 | $22,258 | 187 | Amgen Inc. ($19,522) |
| 2018 | $53,412 | 162 | Amgen Inc. ($43,453) |
| 2017 | $11,328 | 115 | Amgen Inc. ($7,690) |
All Payment Transactions
960 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: PAIN | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: PAIN | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.92 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: PAIN | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/11/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: PAIN | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.56 | General |
| Category: PAIN | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: PAIN | ||||||
| 11/05/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $30.37 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.36 | General |
| Category: Neuroscience | ||||||
| 10/09/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Neuroscience | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 600 | 56,645 | $1.5M | $338,034 |
| 2022 | 9 | 589 | 66,436 | $1.8M | $388,446 |
| 2021 | 8 | 536 | 54,275 | $1.4M | $320,941 |
| 2020 | 7 | 488 | 45,558 | $939,304 | $268,679 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 154 | 55,950 | $1.2M | $271,894 | 22.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 125 | 226 | $130,651 | $28,640 | 21.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 27 | 54 | $56,220 | $9,291 | 16.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $29,437 | $8,256 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 84 | $29,425 | $7,754 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 82 | $20,373 | $5,878 | 28.9% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 26 | 71 | $30,135 | $3,745 | 12.4% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 11 | 35 | $10,817 | $2,207 | 20.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 30 | $1,383 | $349.84 | 25.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 26 | 48 | $72.48 | $20.27 | 28.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 155 | 65,700 | $1.4M | $315,379 | 22.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 128 | 274 | $158,092 | $35,243 | 22.3% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 26 | 53 | $54,489 | $9,338 | 17.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $31,237 | $8,885 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 85 | $29,779 | $8,500 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 95 | $23,593 | $6,550 | 27.8% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 29 | 72 | $33,195 | $4,312 | 13.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 19 | $905.46 | $214.33 | 23.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 16 | 69 | $104.19 | $24.71 | 23.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 144 | 53,700 | $1.1M | $255,482 | 22.8% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 120 | 218 | $123,749 | $28,012 | 22.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 73 | 73 | $32,670 | $9,515 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 84 | $29,278 | $9,074 | 31.0% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 25 | 51 | $51,712 | $8,890 | 17.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 72 | $17,738 | $5,282 | 29.8% |
About Dr. Christy Jackson, M.D
Dr. Christy Jackson, M.D is a Neurology healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619992286.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christy Jackson, M.D has received a total of $213,127 in payments from pharmaceutical and medical device companies, with $9,486 received in 2024. These payments were reported across 960 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($180,890).
As a Medicare-enrolled provider, Jackson has provided services to 2,213 Medicare beneficiaries, totaling 222,914 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location La Jolla, CA
- Active Since 07/13/2006
- Last Updated 11/27/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1619992286
Products in Payments
- Aimovig (Biological) $71,939
- UBRELVY (Drug) $41,358
- NURTEC ODT (Drug) $28,580
- EMGALITY (Drug) $14,840
- QULIPTA (Drug) $12,027
- SPRIX (Drug) $5,532
- Zembrace (Drug) $4,302
- ONZETRA Xsail (Drug) $2,053
- BOTOX (Biological) $1,411
- AJOVY (Biological) $965.28
- APTIOM (Drug) $605.86
- ZEMBRACE SYMTOUCH (Drug) $548.62
- Gocovri (Drug) $415.55
- TROKENDI XR (Drug) $397.31
- VYEPTI (Biological) $366.40
- TOSYMRA (Drug) $270.79
- AIMOVIG (Biological) $248.33
- NUEDEXTA (Drug) $204.96
- ZEPOSIA (Drug) $200.57
- TREXIMET (Drug) $164.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in La Jolla
Charles Smith, M.d, M.D
Neurology — Payments: $590,505
Dr. Jody Corey-Bloom, Md, Phd, MD, PHD
Neurology — Payments: $452,305
Dr. Jay Rosenberg, M.d, M.D
Neurology — Payments: $216,627
Dr. Emily Engel, M.d, M.D
Neurology — Payments: $151,871
Dr. Dee Silver, Md, MD
Neurology — Payments: $103,830
Dr. Douglas Galasko, Md, MD
Neurology — Payments: $76,399